Hofmann, S.; Schubert, M.-L.; Wang, L.; He, B.; Neuber, B.; Dreger, P.; Müller-Tidow, C.; Schmitt, M.
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML). J. Clin. Med. 2019, 8, 200.
https://doi.org/10.3390/jcm8020200
AMA Style
Hofmann S, Schubert M-L, Wang L, He B, Neuber B, Dreger P, Müller-Tidow C, Schmitt M.
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML). Journal of Clinical Medicine. 2019; 8(2):200.
https://doi.org/10.3390/jcm8020200
Chicago/Turabian Style
Hofmann, Susanne, Maria-Luisa Schubert, Lei Wang, Bailin He, Brigitte Neuber, Peter Dreger, Carsten Müller-Tidow, and Michael Schmitt.
2019. "Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)" Journal of Clinical Medicine 8, no. 2: 200.
https://doi.org/10.3390/jcm8020200
APA Style
Hofmann, S., Schubert, M.-L., Wang, L., He, B., Neuber, B., Dreger, P., Müller-Tidow, C., & Schmitt, M.
(2019). Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML). Journal of Clinical Medicine, 8(2), 200.
https://doi.org/10.3390/jcm8020200